The deal was going to close. Your champion loved the product. The demo went well. The business case was solid. Then nothing happened.
No rejection letter. No competitor announcement. No dramatic boardroom showdown. The buying committee just stopped responding. Emails went unanswered. The next meeting never got scheduled. Three months later, the opportunity moved to “Closed-Lost: No Decision” in the CRM.
Your sales team blamed timing. Your VP of Sales blamed lead quality. Your CEO asked Marketing for better leads. Nobody asked the obvious question: why did a qualified buyer who wanted to purchase simply freeze?
The No-Decision Epidemic
Here’s the thing. This isn’t a one-off. It’s the dominant pattern in B2B sales.
Matthew Dixon and Ted McKenna analyzed 2.5 million sales conversations for their research published as The JOLT Effect. Their finding should redefine how every B2B company thinks about pipeline: 40-60% of qualified deals end in no decision. The buyer doesn’t choose a competitor. The buyer doesn’t decide the status quo is fine. The buyer does nothing.
That makes “no decision” the single largest category of deal loss in B2B. Bigger than any competitor, bigger than budget cuts, bigger than bad timing. And it’s been hiding in plain sight because CRMs categorize it as a loss, not as a systemic failure.
The assumption has always been that buyers who go dark preferred the status quo. Dixon and McKenna’s data tells a different story. Of deals lost to inaction, 56% involved buyers who genuinely wanted to change. They recognized the problem. They evaluated solutions. They built internal consensus. Then they couldn’t pull the trigger.
The barrier wasn’t motivation. It was fear.
The Psychology of the Stall
Buyer indecision operates on a different axis than buyer indifference. Indifference means the buyer doesn’t care enough to act. Indecision means the buyer cares, has done the work, and still can’t commit.
I’ve seen this play out the same way across industries. Three fears drive the stall.
The first is the fear of making the wrong choice. With 13 decision-makers now involved in the average B2B purchase, according to Consensus’s 2026 Buyer Behavior Report, the personal risk of championing a bad decision has multiplied. Nobody wants to be the person who pushed for the vendor that failed.
The second is the fear of incomplete information. Gartner’s B2B buying research found 94% of buyers have experienced a cancelled purchase cycle. Think about that for a second. Almost every B2B buyer walking into your sales process has been burned before. They respond by requesting one more reference call, one more proof of concept, one more internal review. Each request feels prudent. Collectively, they create paralysis.
The third is the fear of change itself. Even when the current state is painful, it’s familiar. As I explored in The Invisible Buyer, 95% of B2B buyers purchase from vendors who made their Day One shortlist. But making the shortlist isn’t enough when the committee’s default instinct is caution. The shortlist narrows the options. Indecision prevents the selection.
Indifference means the buyer doesn’t care enough to act. Indecision means the buyer cares, has done the work, and still can’t commit.
The Marketing Blind Spot
The entire B2B marketing apparatus is built to solve the wrong problem.
Lead generation assumes the barrier is awareness. Content marketing assumes the barrier is education. Demand generation assumes the barrier is interest. All of these address the top of the funnel, where the buyer doesn’t yet know they have a problem.
But 40-60% of pipeline loss happens after the buyer already knows, already cares, and already evaluated. The barrier isn’t demand. It’s confidence.
And this is where most marketing organizations completely disengage. Once a lead becomes an opportunity, marketing hands it to Sales and moves on to the next campaign. “Sales owns the close.” That’s the mantra. But the data shows Sales isn’t losing to competitors. Sales is losing to a room full of people who can’t agree that the risk is worth taking.
Kondo’s 2025 B2B Sales Trends Report found 43% of sales leaders reported increased sales cycle length over the past year. Deals aren’t dying faster. They’re dying slower, bleeding out in committee meetings where nobody has the confidence to say “yes.”
The data shows Sales isn’t losing to competitors. Sales is losing to a room full of people who can’t agree that the risk is worth taking.
The Cost Nobody Calculates
Companies meticulously track win rates against competitors. They build battle cards. They train sales teams on competitive positioning. They invest millions in differentiation.
Almost nobody tracks the cost of indecision. Does that seem right to you?
Consider the math. If a company has $50 million in qualified pipeline and 50% ends in no decision, that’s $25 million in deals where the buyer wanted to buy and couldn’t commit. Improving the competitive win rate by 10% might add a few million in revenue. Reducing the no-decision rate by 10% unlocks pipeline that was already qualified, already engaged, and already interested. The ROI isn’t even close.
The companies that understand this are shifting resources from “generate more leads” to “reduce buyer risk.” They’re building business cases that the buying committee can defend internally. They’re creating content that addresses the CFO’s objections before the champion has to. They’re providing implementation roadmaps that make the transition feel manageable rather than terrifying.
What This Actually Requires
The fix isn’t a new sales methodology. It’s a fundamental rethinking of what marketing produces after the lead converts.
Most marketing teams measure success by pipeline created. Few measure pipeline progressed. Even fewer measure pipeline lost to inaction, let alone have a strategy for preventing it. From my experience, this is one of the biggest blind spots in B2B marketing operations.
Three shifts matter.
The first is treating buying committee confidence as a marketing KPI. If 13 people need to agree, marketing needs to equip the champion with materials that address each stakeholder’s specific fears. The CFO wants financial risk mitigation. The IT lead wants integration assurance. The end users want transition support. One generic case study won’t serve all 13.
The second is building “de-risk” content alongside “demand” content. For every piece of content that generates awareness, create a corresponding piece that reduces perceived risk. Peer comparison data. Independent validation. Implementation timelines from similar companies. The content that closes deals looks nothing like the content that opens them.
The third is measuring the no-decision rate and treating it as a strategic metric. If more than 40% of qualified pipeline ends in no decision, the problem isn’t lead quality. The problem is that the buying committee doesn’t have enough confidence to commit. That’s a marketing problem wearing a sales disguise.
The content that closes deals looks nothing like the content that opens them.
The Uncomfortable Implication
B2B companies have spent decades optimizing for demand generation. The implicit assumption: if we create enough awareness and interest, pipeline will convert. The data says the bottleneck moved years ago.
Sure, awareness matters. Education matters. Interest matters. But none of them are the constraint anymore. Confidence is the constraint. And confidence doesn’t come from another whitepaper or webinar. It comes from reducing the perceived risk of saying yes.
The hard truth is that most companies respond to stalled pipeline by generating more leads. More top-of-funnel activity. More campaigns. More MQLs. They’re filling a leaky bucket and blaming the faucet for the puddle on the floor.
Your biggest competitor has never heard of you. It’s sitting in a conference room, shared across 13 people who agreed something needed to change and then quietly decided that doing nothing felt safer than getting it wrong.
